Press Release Details

Call for Nominations
Nominations Deadline: February 29, 2004

Seattle (January 5, 2004) – Amgen Inc. (NASDAQ:AMGN), the world's largest biotechnology company, today announced it has begun accepting nominations for the 2004 Amgen Award for Science Teaching Excellence in King and Snohomish counties, the company's recognition program for science education. Two K-12 educators who work in either public or private schools in those two counties will each receive an unrestricted $10,000 award from Amgen, and will be honored at an award dinner in May.

For 12 years, Amgen has conducted a teaching award program, and recently modified the award to focus solely on excellence in science teaching. This will be the second year the Amgen Award for Science Teaching Excellence has been conducted in Washington and is directed toward teachers in King and Snohomish counties. Amgen also conducts similar programs in California; Colorado; Louisville, Kentucky; Boston and Cambridge, Massachusetts; Puerto Rico; and Rhode Island.

Anyone can nominate an educator who teaches science. The nomination letter should include: the full name of the teacher; the name and address of the school; the name of the school district; the school's phone number; the grade level taught by the science teacher; the nominator's relationship to the science teacher; the nominator's phone number; and a description of why the science teacher deserves the award. The letter should describe the teacher's attributes in the areas of creativity, teaching effectiveness, best practice development, and instructional and motivational ability.

Letters should be sent to: Amgen's Award for Science Teaching Excellence, Amgen Washington, Attn: Janis Wignall, 51 University Street, Seattle, WA 98101. Nominations can also be submitted electronically, at www.Amgen.com/ScienceTeacherAward/. Nominations for the award will be accepted immediately, through February 29, 2004.

Amgen Announces Award for Science Teaching Excellence

Amgen is a leading global biotechnology company that discovers, develops, manufactures and markets important human therapeutics based on advances in cellular and molecular biology.

CONTACT: Kristin Wennberg (206) 265-4061
Amgen, Corporate Communications

EDITORS NOTE: An electronic version of this news release may be accessed via our Web site at www.amgen.com. Journalists and media representatives may sign up to receive all news releases electronically at the time of announcement by filling out a short form in the Media section of the Web site.